1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
2
|
Reddy OL, Cates JM, Gellert LL, Crist HS,
Yang Z, Yamashita H, Taylor JA III, Smith JA Jr, Chang SS, Cookson
MS, et al: Loss of FOXA1 drives sexually dimorphic changes in
urothelial differentiation and is an independent predictor of poor
prognosis in bladder cancer. Am J Pathol. 185:1385–1395. 2015.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Szarvas T, László V, Vom Dorp F, Reis H,
Szendröi A, Romics I, Tilki D, Rübben H and Ergün S: Serum
endostatin levels correlate with enhanced extracellular matrix
degradation and poor patients' prognosis in bladder cancer. Int J
Cancer. 130:2922–2929. 2012. View Article : Google Scholar
|
4
|
Yang GL, Zhang LH, Bo JJ, Huo XJ, Chen HG,
Cao M, Liu DM and Huang YR: Increased expression of HMGB1 is
associated with poor prognosis in human bladder cancer. J Surg
Oncol. 106:57–61. 2012. View Article : Google Scholar : PubMed/NCBI
|
5
|
Dobruch J, Daneshmand S, Fisch M, Lotan Y,
Noon AP, Resnick MJ, Shariat SF, Zlotta AR and Boorjian SA: Gender
and bladder cancer: A collaborative review of etiology, biology,
and outcomes. Eur Urol. 69:300–310. 2016. View Article : Google Scholar
|
6
|
Mitra AP: Molecular substratification of
bladder cancer: Moving towards individualized patient management.
Ther Adv Urol. 8:215–233. 2016. View Article : Google Scholar : PubMed/NCBI
|
7
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
8
|
Takamizawa J, Konishi H, Yanagisawa K,
Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y,
et al: Reduced expression of the let-7 microRNAs in human lung
cancers in association with shortened postoperative survival.
Cancer Res. 64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
9
|
Zhang DQ, Zhou CK, Jiang XW, Chen J and
Shi BK: Increased expression of miR-222 is associated with poor
prognosis in bladder cancer. World J Surg Oncol. 12:2412014.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Kohler CU, Bryk O, Meier S, Lang K,
Rozynek P, Brüning T and Käfferlein HU: Analyses in human
urothelial cells identify methylation of miR-152, miR-200b and
miR-10a genes as candidate bladder cancer biomarkers. Biochem
Biophys Res Commun. 438:48–53. 2013. View Article : Google Scholar : PubMed/NCBI
|
11
|
Puerta-Gil P, Garcia-Baquero R, Jia AY,
Ocaña S, Alvarez-Múgica M, Alvarez-Ossorio JL, Cordon-Cardo C, Cava
F and Sánchez-Carbayo M: miR-143, miR-222, and miR-452 are useful
as tumor stratification and noninvasive diagnostic biomarkers for
bladder cancer. Am J Pathol. 180:1808–1815. 2012. View Article : Google Scholar : PubMed/NCBI
|
12
|
Zhang J, Su B, Gong C, Xi Q and Chao T:
miR-214 promotes apoptosis and sensitizes breast cancer cells to
doxorubicin by targeting the RFWD2-p53 cascade. Biochem Biophys Res
Commun. 478:337–342. 2016. View Article : Google Scholar : PubMed/NCBI
|
13
|
Yu X, Luo A, Liu Y, Wang S, Li Y, Shi W,
Liu Z and Qu X: MiR-214 increases the sensitivity of breast cancer
cells to tamoxifen and fulvestrant through inhibition of autophagy.
Mol Cancer. 14:2082015. View Article : Google Scholar : PubMed/NCBI
|
14
|
Li QQ, Xie YK, Wu Y, Li LL, Liu Y, Miao
XB, Liu QZ, Yao KT and Xiao GH: Sulforaphane inhibits cancer
stem-like cell properties and cisplatin resistance through
miR-214-mediated downregulation of c-MYC in non-small cell lung
cancer. Oncotarget. 8:12067–12080. 2017.PubMed/NCBI
|
15
|
Wang J, Zhang X, Wang L, Yang Y, Dong Z,
Wang H, Du L and Wang C: MicroRNA-214 suppresses oncogenesis and
exerts impact on prognosis by targeting PDRG1 in bladder cancer.
PLoS One. 10:e01180862015. View Article : Google Scholar : PubMed/NCBI
|
16
|
Wang J, Zhang X, Wang L, Dong Z, Du L,
Yang Y, Guo Y and Wang C: Downregulation of urinary cell-free
microRNA-214 as a diagnostic and prognostic biomarker in bladder
cancer. J Surg Oncol. 111:992–999. 2015. View Article : Google Scholar : PubMed/NCBI
|
17
|
Pan X, Peng G, Liu S, Sun Z, Zou Z and Wu
G: MicroRNA-4649-3p inhibits cell proliferation by targeting
protein tyrosine phosphatase SHP-1 in nasopharyngeal carcinoma
cells. Int J Mol Med. 36:559–564. 2015. View Article : Google Scholar : PubMed/NCBI
|
18
|
Paradisi A, Creveaux M, Gibert B, Devailly
G, Redoulez E, Neves D, Cleyssac E, Treilleux I, Klein C,
Niederfellner G, et al: Combining chemotherapeutic agents and
netrin-1 interference potentiates cancer cell death. EMBO Mol Med.
5:1821–1834. 2013. View Article : Google Scholar : PubMed/NCBI
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
20
|
Long LM, He BF, Huang GQ, Guo YH, Liu YS
and Huo JR: microRNA-214 functions as a tumor suppressor in human
colon cancer via the suppression of ADP-ribosylation factor-like
protein 2. Oncol Lett. 9:645–650. 2015. View Article : Google Scholar : PubMed/NCBI
|
21
|
Chen DL, Wang ZQ, Zeng ZL, Wu WJ, Zhang
DS, Luo HY, Wang F, Qiu MZ, Wang DS, Ren C, et al: Identification
of microRNA-214 as a negative regulator of colorectal cancer liver
metastasis by way of regulation of fibroblast growth factor
receptor 1 expression. Hepatology. 60:598–609. 2014. View Article : Google Scholar : PubMed/NCBI
|
22
|
Wang YB, Qin J, Zheng XY, Bai Y, Yang K
and Xie LP: Diallyl trisulfide induces Bcl-2 and
caspase-3-dependent apoptosis via downregulation of Akt
phosphorylation in human T24 bladder cancer cells. Phytomedicine.
17:363–368. 2010. View Article : Google Scholar
|
23
|
Liu J, Kong CZ, Gong DX, Zhang Z and Zhu
YY: PKC α regulates netrin-1/UNC5B-mediated survival pathway in
bladder cancer. BMC Cancer. 14:932014. View Article : Google Scholar
|